AAN 2023 | MS highlights at AAN: BTK inhibitors

Augusto A. Miravalle, MD, FAAN, University of Colorado School of Medicine, Aurora, CO, discusses the AAN 2023 meeting, which combined networking with continuous medical education and training. Bruton tyrosine kinase inhibitors were a major point of discussion at AAN, with many experts hoping that they can fill the void in current multiple sclerosis therapies. This interview took place at the American Academy of Neurology Annual Meeting 2023 in Boston, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.